Background: Theranostics, an emerging technique that combines therapeutic and diagnostic modalities for various diseases, holds promise to detect cancer in early stages, eradicate metastatic tumors and ultimately reduce cancer mortality.
Methods & Results: This study reports unique polymer nanoassemblies that increase fluorescence intensity upon addition of hydrophobic drugs and either increase or decrease fluorescence intensity in acidic environments, depending on nanoparticle core environment properties. Extensive spectroscopic analyses were performed to determine optimal excitation and emission wavelengths, which enabled real time measurement of drugs releasing from the nanoassemblies and ex vivo imaging of acidic liver metastatic tumors from mice.
Conclusion: Polymer nanoassemblies with solvato- and halo-fluorochromic properties are promising platforms to develop novel theranostic tools for the detection and treatment of metastatic tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977001 | PMC |
| http://dx.doi.org/10.4155/tde.15.59 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fluidic Membrane-Bound Protocells Enabling Versatile Assembly of Functional Nanomaterials for Biomedical Applications.
ACS Nano
December 2024
Department of Biomedical Engineering, City University of Hong Kong, Y6700, 6/F, Yellow Zone, Yeung Kin Man Academic Building, 83 Tat Chee Avenue, Kowloon, Hong Kong 999077, China.
The development of membrane-bound protocells, which process cascade biochemical reactions in distinct microcompartments, marks a significant advancement in soft systems. However, many synthesized protocells with cell membrane-like structures are prone to rupturing in biological environments and are challenging to functionalize, limiting their biomedical applications. In this study, we explore the liquid-liquid phase separation of tannic acid (TA) and polyethylene glycol (PEG) to form coacervate droplets.
View Article and Find Full Text PDFBionanoparticles with In Situ Nitric Oxide Release for Precise Modulation of ER-TRPV1 Ion Channels in Multimodal Killing of Glioblastoma.
Small
November 2024
Innovation and Research Institute of Hebei University of Technology in Shijiazhuang, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Xiping Road, Tianjin, 300130, P. R. China.
Article Synopsis
- Glioblastoma (GBM) is difficult to treat due to its immunosuppressive environment and resistance to therapies, with the TRPV1 ion channel playing a key role in tumor growth control.
- A novel approach using a biomimetic nanoassembly (M-UCN-T) is designed to precisely release nitric oxide (•NO) to activate the TRPV1 channels, enhancing treatment effectiveness.
- By targeting both tumor cells and the endoplasmic reticulum, this method aims to trigger stress pathways in multiple organelles, leading to improved tumor cell destruction.
Self-assembly, cytocompatibility, and interactions of desmopressin with sodium polystyrene sulfonate.
Soft Matter
December 2024
Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo 04062-000, Brazil.
Peptide-polymer systems hold strong potential for applications in nanotherapeutics. Desmopressin, a synthetic analogue of the antidiuretic hormone arginine vasopressin, may serve as a valuable case of study in this context since it is a first-line treatment for disorders affecting water homeostasis, including diabetes insipidus. It also has an established use as a hemostatic agent in von Willebrand disease, and recently, its repurposing has been suggested as a neoadjuvant in the treatment of certain types of cancer.
View Article and Find Full Text PDFTargeted Delivery and ROS-Responsive Release of Lutein Nanoassemblies Inhibit Myocardial Ischemia-Reperfusion Injury by Improving Mitochondrial Function.
Int J Nanomedicine
November 2024
Department of Pharmacology, Harbin Medical University, Heilongjiang, 163319, People's Republic of China.
Purpose: Myocardial ischemia-reperfusion injury (MI/RI) is associated with increased oxidative damage and mitochondrial dysfunction, resulting in an elevated risk of mortality. MI/RI may be alleviated by protecting cardiomyocytes from oxidative stress. Lutein, which belongs to a class of carotenoids, has proven to be effective in cardiovascular disease treatment due to its remarkable antioxidant properties, but its application is limited due to its poor stability and low bioavailability in vivo.
View Article and Find Full Text PDFDextran-based nanodrugs with mitochondrial targeting/glutathione depleting synergy for enhanced photodynamic therapy.
Carbohydr Polym
January 2025
State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address:
The efficacy of photodynamic therapy (PDT) for malignant tumors is significantly impeded by the short diffusion distance of reactive oxygen species (ROS) and the ROS-consuming glutathione (GSH) overexpressed in tumor cells. Therefore, enhanced PDT can be achieved by the construction of biomacromolecule-based nanodrugs that can specifically target ROS-sensitive mitochondria and deplete intracellular GSH. Herein, we synthesized the dextran-based nano-assemblies by a Graft copolymerization Induced Self-Assembly (GISA) method, in which methyl acrylate and diallyl disulfide (DADS) were copolymerized from a mixed dextran/amino dextran backbone in an aqueous medium.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!